March 15 (Reuters) - Novelion Therapeutics Inc NVLN.TO
* Novelion therapeutics reports preliminary fourth quarter & full year 2016 financial results
* Novelion therapeutics inc- company reiterated net product sales financial guidance for full year 2017
* Novelion therapeutics inc- gaap total net product sales for q4 of 2016 were $13.6 million compared to prior year's q4 revenues of $0 million
* Novelion therapeutics inc qtrly loss per share $1.50
* Novelion therapeutics inc qtrly non-gaap loss per share basic $1.72 Source text for Eikon: ID:nGNXNQTQFa Further company coverage: NVLN.TO